Crescent Biopharma to Present at November Investor Conferences

Core Insights - Crescent Biopharma is focused on advancing innovative therapies for cancer patients, with a vision to become a leading oncology company [2] Company Overview - Crescent Biopharma's pipeline includes a PD-1 x VEGF bispecific antibody and novel antibody-drug conjugates (ADCs) aimed at treating various solid tumors [2] - The company utilizes multiple modalities and established targets to develop transformative therapies, either as standalone treatments or in combination regimens [2] Upcoming Events - Crescent Biopharma will present at several investor conferences in November 2025, including: - Guggenheim 2 Annual Healthcare Innovation Conference on November 11, 2025, at 8:00 a.m. ET in Boston [3] - Stifel 2025 Healthcare Conference on November 12, 2025, at 1:20 p.m. ET in New York [3] - Jefferies Global Healthcare Conference on November 19, 2025, at 9:30 a.m. GMT (4:30 a.m. ET) in London [3]